Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
By Tony Dutra
Sept. 12 --Acting Director of the Patent and Trademark Office Teresa Stanek Rea announced that she is stepping down from the position “in the near future,” according to a Sept. 12 internal employee email.
“It has been a tremendous honor and a true pleasure to serve with you as Deputy Director and Acting Director of the USPTO, America's own 'innovation agency,'” she told the agency's staff. “Thank you for the privilege of serving with you.”
Rea took over the position Feb. 1 (15 PTD, 1/23/13), when David J. Kappos left to join the New York office of Cravath, Swaine & Moore (23 PTD, 2/4/13). The search for Kappos's replacement was put on hold until Penny Pritzker (87 PTD, 5/6/13) was confirmed as the new head of the U.S. Department of Commerce on June 26. Rea indicated that Pritzker is ready to name a permanent PTO director.
“It is my anticipation that we will soon welcome a new Director who will continue guiding the excellent work of the agency,” Rea said in the message. “Until then, I will do everything I can to ensure a smooth transition.”
Rea is a seasoned patent practitioner with expertise in pharmaceuticals, biotechnology and nanotechnology, and with service as a past president of the American Intellectual Property Law Association (134 PTD, 7/16/09) and of the National Inventors Hall of Fame. She was a partner in Crowell and Moring LLP's Washington, D.C., office until she was appointed to the post of PTO deputy director in February 2011 (34 PTD, 2/18/11).
The PTO implemented the America Invents Act during Rea's tenure with her constant involvement in moderating hearings (201 PTD, 10/18/11); (09 PTD, 1/14/13) and representing the agency at stakeholder association meetings (184 PTD, 9/22/11); (52 PTD, 3/18/13), and with her general advocacy through the PTO's “Director's Forum.”
Rea also was largely responsible for working with foreign patent offices (217 PTD, 11/9/11) as deputy director, and she carried on Kappos's emphasis on international harmonization of patent issues (23 PTD, 2/4/13) as director.
To contact the reporter on this story: Tony Dutra in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Naresh Sritharan at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)